Skip to content

Clinical trials

Phase 2 Myocardial Infarction trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 2 Country / region: Czechia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20151
20161
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abcentra1
Bayer1
Boehringer Ingelheim1
Cardior Pharmaceuticals GmbH1
Fibrex Medical Research & Development GmbH1
Janssen Research & Development, LLC1
KAI Pharmaceuticals1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction8
Myocardial Ischemia3
Acute Coronary Syndrome2
Angina, Unstable2
Heart Diseases2
Cardiovascular Diseases1
Coronary Disease1
Heart Failure1
Infarction1
Inflammation1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.